Lithium protects against anesthesia-induced developmental neuroapoptosis

Area of Science:

• Neuroscience
• Developmental Biology
• Pharmacology

Background:

• Ethanol and anesthetic drugs can cause neuroapoptosis in developing brains.
• Ethanol-induced neuroapoptosis is linked to reduced extracellular signal-regulated protein kinase (ERK) phosphorylation.
• Lithium has shown potential in counteracting ethanol's effects on ERK and neuroapoptosis.

Purpose of the Study:

• To investigate if ketamine and propofol suppress ERK phosphorylation like ethanol.
• To determine if lithium can prevent this suppression and subsequent neuroapoptosis caused by these anesthetics.

Main Methods:

• Postnatal day 5 mice were administered ketamine, propofol, lithium, or combinations thereof.
• Western blot analysis assessed phosphorylated ERK and protein kinase levels.
• Immunohistochemistry identified activated caspase-3 to quantify neuroapoptosis.

Main Results:

• Ketamine and propofol were found to suppress phosphorylated ERK.
• Lithium effectively counteracted the ERK suppression induced by both anesthetics.
• Lithium also mitigated the neuroapoptotic effects of ketamine and propofol.

Conclusions:

• Ketamine and propofol trigger neuroapoptosis by suppressing ERK phosphorylation.
• Lithium can counteract this effect, suggesting a protective role.
• Further research into lithium's safety for pediatric/obstetric use could lead to strategies preventing anesthesia-induced neurodevelopmental harm.